What is it about?
Amidst the global outbreak of the COVID-19 pandemic, the clinical trial landscape underwent significant disruptions and transformations. The unprecedented nature of the crisis imposed multiple challenges on trial design, implementation, participant recruitment, regulatory approvals, and data collection. This paper provides a comprehensive overview of the multifaceted challenges faced by clinical research teams worldwide during the pandemic.
Featured Image
Photo by benjamin lehman on Unsplash
Why is it important?
It highlights key issues such as trial delays, site closures, reduced patient enrollment, logistical constraints, and ethical dilemmas concerning patient safety and informed consent. Furthermore, the paper explores adaptive strategies adopted to sustain research continuity, including the rapid shift towards decentralized trial models, remote monitoring, and increased use of digital health technologies.
Perspectives
Its my pleasure to publish my article in such a reputed journal. Its quality and its access across the globe make this journal one of the best journal.
Vinay Singh
Maulana Azad Medical College
Read the Original
This page is a summary of: COVID-19 and Clinical Trials: Current Challenges and Future Directions, Reviews on Recent Clinical Trials, July 2021, Bentham Science Publishers,
DOI: 10.2174/1574887116666210122160705.
You can read the full text:
Contributors
The following have contributed to this page
